Post Conditioning in PCI for Acute ST Elevation Myocardial Infarction

May 26, 2015 updated by: Todd Anderson, University of Calgary

The purpose of this trial is to compare post-conditioning to standard angioplasty (50/50 chance) in patients who present with an acute heart attack and are taken directly for an angioplasty procedure. Post conditioning is a procedure that involves balloon inflation followed by deflation in a series of cycles that appears to show (based on early data) that it can decrease the amount of damage to the heart muscle as compared to standard angioplasty procedures.

Hypothesis: For Subjects undergoing direct PCI for STEMI, post conditioning with cycles of balloon inflation/deflation within the first minute following the re-establishment of coronary blood blow, will decrease the amount of irreversible myocardial damage assessed by delayed enhancement contrast CMR.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

In patients who suffer a myocardial infarction, the blood flow usually ceases due to plaque rupture leading to thrombus formation and vessel occlusion. The resultant entity is known as ST Elevation segment myocardial infarction (STEMI) and is a significant health issue in industrialized countries. There are over 50,000 STEMI's every year in Canada and up to 10% of these patients die in hospital and another 10% die within the first year after their heart attack. The more common problem however is not death, but irreparable damage to the left ventricle leading to LV dysfunction and subsequent heart failure and arrythmias. Re-establishing blood flow promptly by administering plasminogen activators (lytics) or mechanically by performing angioplasty is possible and has lowered the mortality rate dramatically.

Although reperfusion is necessary, it gives rise to an entity known as ischemia-reperfusion where acutely re-establishing blood flow and oxygen levels of the heart has detrimental effects. Clinically this is manifested as no-reflow that causes subsequent damage to the left ventricle and decreases the beneficial affect of early reperfusion by PCI. The ischemia-reperfusion effect sets off a molecular cascade of events involving unfavorable interaction between neutrophils, platelets and endothelium, that is fairly well identified. Efforts to pharmacologically block this effect have not proven to be particularly effective.

Post conditioning follows from a concept of pre-conditioning in animals that showed a decrease in myocardial infarct size. Pre-conditioning is not useful as it requires to be performed prior to the development of ischemia/injury. Post conditioning in preliminary studies with animals and one small study in humans have shown promising results for decrease in infarct size. Post conditioning is a procedure of gradual conditioning in which the artery is opened and closed in cycles with inflation/deflation of the culprit artery followed immediately by standard PCI and placement of stent.

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Calgary, Alberta, Canada, T2N 2T9
        • Foothills Medical Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years and over
  • ST elevation of >/= 2mm in 3 consecutive anterior leads or >/= to 2 mm in leads II, III and AVF with total 8 mm ST shift (ST depression of 1 mm in ant or lat leads)

Exclusion Criteria:

  • Cardiogenic shock or severe heart failure
  • Inability to undergo CMR (metallic objects or claustrophobia)
  • Previous MI
  • TIMI 2-3 flow in target artery
  • Collaterals to infarct related artery > Rentrop grade 1
  • Inability to undertake successful PCI at time of angio
  • Significant LM disease or requiring CABG during hospital stay
  • Inability to proceed with post conditioning within 1 minute of establishing blood flow in culprit artery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Post conditioning
Balloon inflations-deflations
4 cycles of balloon inflation /deflation (post-conditioning) within first minute of opening up artery in primary PCI for STEMI vs usual balloon inflation sequence
Placebo Comparator: Standard care
No balloon inflations
4 cycles of balloon inflation /deflation (post-conditioning) within first minute of opening up artery in primary PCI for STEMI vs usual balloon inflation sequence

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Infarct size as measured by: salvage index = total area at risk - infarct size/total area at risk
Time Frame: 3-5 days post MI
3-5 days post MI

Secondary Outcome Measures

Outcome Measure
Time Frame
Corrected TIMI frame count (cTFC)
Time Frame: Immediately post PCI
Immediately post PCI
Myocardial blush score
Time Frame: Immediately post PCI
Immediately post PCI
CK release (under the curve)
Time Frame: 1st 48 hours post MI
1st 48 hours post MI
ST segment resolution by 48 hrs compared with admission
Time Frame: 1st 48 hours post MI
1st 48 hours post MI
MRI infarct size
Time Frame: 3-5 days and 6 months
3-5 days and 6 months
MRI maximal transmural extent of irreversible injury
Time Frame: 3-5 days and 6 months
3-5 days and 6 months
CMR regional end-systolic wall stress
Time Frame: 3-5 days and 6 months
3-5 days and 6 months
CMR Myocardial perfusion
Time Frame: 3-5 days and 6 months
3-5 days and 6 months
CMR Myocardial oxygenation
Time Frame: 3-5 days and 6 months
3-5 days and 6 months
Peripheral endothelial function testing (brachial u/s and pulse arterial tonometry) in hospital
Time Frame: 3-5 days post MI
3-5 days post MI
CMR quantification of volume of no-reflow
Time Frame: 3-5 days and 6 months
3-5 days and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mouhieddin Traboulsi, MD, University of Calgary, sub-investigator
  • Study Chair: Matthias Friedrich, MD, Sub-investigator, Stephenson CMR Centre, FMC; 1403-29th St NW, Calgary; T2N 2T9

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2006

Primary Completion (Actual)

October 1, 2011

Study Completion (Actual)

October 1, 2011

Study Registration Dates

First Submitted

June 6, 2006

First Submitted That Met QC Criteria

June 6, 2006

First Posted (Estimate)

June 7, 2006

Study Record Updates

Last Update Posted (Estimate)

May 28, 2015

Last Update Submitted That Met QC Criteria

May 26, 2015

Last Verified

May 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Infarction

Clinical Trials on Post conditioning

3
Subscribe